Remak Cells

Remak Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Remak Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
</table>

Remak cells are non-myelinating Schwann cells that ensheath bundles of unmyelinated axons in the peripheral nervous system. Named after the German anatomist Robert Remak who first described them in the 1830s, these cells play essential roles in axon maintenance, nerve regeneration, and neuropathic pain. Remak cell dysfunction is implicated in various peripheral neuropathies and chronic pain conditions[@jessen2005].

Overview

Remak Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Remak Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
</table>

Remak cells are non-myelinating Schwann cells that ensheath bundles of unmyelinated axons in the peripheral nervous system. Named after the German anatomist Robert Remak who first described them in the 1830s, these cells play essential roles in axon maintenance, nerve regeneration, and neuropathic pain. Remak cell dysfunction is implicated in various peripheral neuropathies and chronic pain conditions[@jessen2005].

Overview

Unlike their counterparts that form myelin (myelinating Schwann cells), Remak cells surround multiple small-diameter axons (C-fibers and Adelta-fibers) together within a single Schwann cell groove. This association begins during development when Schwann cells destined to become Remak cells fail to radially sort large-diameter axons, instead maintaining them in bundles["@feltri2016"].

Remak cells express distinct molecular markers including:

• S100: Calcium-binding protein
• [GFAP](/entities/gfap): Glial fibrillary acidic protein (variable)
• P75NTR: Low-affinity nerve growth factor receptor
• Sox2: Neural stem cell marker

• Lack of myelin basic protein expression
• Absence of compact myelin formation
• Multiple axon ensheathment per cell
• Distinct transcription factor profiles["@bhide1996"]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Structure

Cell Body

Remak cell somata are located along the length of peripheral nerves, typically 10-20 μm in length. The nucleus is elongated, and the cytoplasm contains characteristic intermediate filaments.

Processes

Remak cells extend multiple longitudinal processes that create grooves (cervices) for axon bundling. Each Remak cell can ensheath 5-20 unmyelinated axons of varying diameters.

Basal Lamina

Unlike [astrocytes](/entities/astrocytes), Remak cells are surrounded by a basal lamina that:

• Provides structural support
• Contains laminin and collagen IV
• Separates the Schwann cell from the extracellular matrix
• Guides axonal regeneration

Function

Axon Maintenance

Remak cells provide critical trophic support to unmyelinated axons:

• Supply of neurotrophic factors (NGF, BDNF, GDNF)
• Metabolic support through glucose transport
• Regulation of axonal calcium levels
• Protection from oxidative stress[@nave2008]

Conduction

While they do not generate saltatory conduction, Remak cells influence conduction in unmyelinated fibers:

• Maintain appropriate extracellular ion balance
• Provide structural organization
• Modulate axon-neighbor interactions

Regeneration

Following nerve injury, Remak cells are crucial for regeneration:

• Proliferate to form Bands of Bungner
• Guide regenerating axons
• Express regeneration-associated genes
• Dedifferentiate similarly to myelinating Schwann cells

Neuropathic Pain

Remak Cell Involvement

Remak cells are key players in neuropathic pain development:

• Transdifferentiation: In response to injury, Remak cells can adopt a pain-sensing phenotype
• Cytokine production: Release IL-1β, TNF-α, and other pro-inflammatory mediators
• Nerve growth factor: Increased NGF sensitizes nociceptors
• Sympathetic sprouting: Remak cells can support sympathetic axon growth into skin[@ren2019]

Pain Targets

Several pain therapies target Remak cell function:

• Antidepressants: Amitriptyline reduces Schwann cell cytokine production
• Anticonvulsants: Gabapentin modulates Remak cell-neuron interactions
• NGF antibodies: Tanezumab targets NGF-mediated sensitization

Disease Associations

Diabetic Neuropathy

Remak cell dysfunction contributes to diabetic peripheral neuropathy:

• Hyperglycemia damages Remak cells
• Reduced trophic factor support
• Impaired axon maintenance
• Contributes to sensory loss and pain

Chemotherapy-Induced Neuropathy

Chemotherapeutic agents target Remak cells:

• Vincristine disrupts cytoskeleton
• Taxanes cause microtubule dysfunction
• Platinum compounds damage DNA

Charcot-Marie-Tooth Disease

Some CMT subtypes involve Remak cells:

• CMT1X (connexin-32 mutations)
• CMT2 (primarily axonal)
• CMT4 (hypomyelinating forms)

Guillain-Barré Syndrome

Autoimmune attacks can target Remak cells:

• Molecular mimicry
• Antibody-mediated damage
• Inflammatory demyelination affects Remak regeneration

Therapeutic Approaches

Pharmacological

• Neurotrophic factors: GDNF, BDNF administration
• Anti-inflammatory agents: Minocycline ([microglia](/entities/microglia)/Schwann cell modulation)
• Ion channel blockers: Sodium channel modulators

Cellular Therapy

• Schwann cell transplantation: Support regeneration
• Stem cell-derived Schwann cells: iPSC approaches
• Gene therapy: BDNF, GDNF delivery

Surgical

• Nerve decompression: For entrapment neuropathies
• Nerve grafting: For nerve transection
• Neuromodulation: For chronic pain

Research Models

In Vitro

• Primary Schwann cell cultures
• Co-cultures with [neurons](/entities/neurons)
• iPSC-derived Schwann cells

In Vivo

• Mouse models of nerve injury
• Transgenic mouse lines
• Zebra fish models (genetic screening)

Background

The study of Remak Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Schwann Cell - Wikipedia](https://en.wikipedia.org/wiki/Schwann_cell)
• [Peripheral Neuropathy - NIH/NINDS](https://www.ninds.nih.gov/Disorders/All-Disorders/Peripheral-Neuropathy-Information-Page)
• [Foundation for Peripheral Neuropathy](https://www.foundationforpn.org/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Remak Cells discovered through SciDEX knowledge graph analysis: